Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G-protein-coupled inwardly-rectifying potassium (GIRK) channels are a family of potassium channels (Kir3.1 to Kir3.4) that play a fundamental role in controlling cellular excitability. These channels are uniquely activated by the direct binding of G-protein beta-gamma (Gβγ) subunits following the stimulation of Gi/o-coupled G protein-coupled receptors (GPCRs) such as muscarinic M2, GABA-B, and opioid receptors (Lüscher & Slesinger, 2010, Nature Reviews Neuroscience). In the heart, GIRK channels (specifically GIRK1/GIRK4 heteromers) mediate the vagal slowing of the heart rate, while in the brain, they contribute to inhibitory postsynaptic potentials and regulate neuronal firing (Hibino et al., 2010, Physiological Reviews). Dysfunction or mutations in GIRK channels are implicated in various pathologies, including atrial fibrillation, epilepsy, and primary aldosteronism (Whorton & MacKinnon, 2013, Cell). Because of their widespread involvement in neurotransmission and cardiac rhythm, they are considered promising therapeutic targets for treating arrhythmias and neuropsychiatric conditions (Nimitvilai et al., 2018, Journal of Neuroscience Research).
Activation by G-protein beta-gamma (Gβγ) subunits released from Gi/o-coupled G protein-coupled receptors (GPCRs), resulting in potassium efflux and membrane hyperpolarization.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G-protein-coupled inwardly-rectifying potassium channel (GIRK) (GIRK).